Transforming Growth Factor-beta Polymorphisms and Cardiac Allograft Rejection

Journal of Heart and Lung Transplantation

Volumn 28, Issue 10, 2009, Pages 1057-1062

  Benza, Raymond L ^a   Coffey, Christopher S ^b   Pekarek, Dawn M ^c   Barchue, Joseph P ^c   Tallaj, Jose A ^c   Passineau, Michael J ^a   Grenett, Hernan E ^c  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c Nutrition Sciences and Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ALLELE; ARTICLE; CARDIAC GRAFT REJECTION; CODON; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GRAFT RECIPIENT; GROUPS BY AGE; HAZARD ASSESSMENT; HEART GRAFT; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HOMOLOGOUS;

EID: 70349248141     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.06.001     Document Type: Article

References (17)

1. Wong B.W., Rahmani M., Rezai N., et al. Progress in heart transplantation. Cardiovasc Pathol 14 (2005) 176-180
2. Bourge R.C., Rodriguez E.R., and Tan C.D. Cardiac allograft rejection. In: Kirklin J.K., Young J.B., and McGiffin D.C. (Eds). Heart transplantation (2001), Churchill Livingstone, New York 464-520
3. Stewart S., Winters G.L., Fishbein M.C., et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 24 (2005) 1710-1720
4. Rao M., Guo D., Jaber B.L., et al. Transforming growth factor-beta 1 gene polymorphisms and cardiovascular disease in hemodialysis patients. Kidney Int 66 (2004) 419-427
5. Densem C.G., Hutchinson I.V., Yonan N., et al. Donor and recipient-transforming growth factor-beta 1 polymorphism and cardiac transplant-related coronary artery disease. Transplant Immunol 13 (2004) 211-217
6. Age distribution of heart recipients (2007). www.ishlt/registries/quarterlyDataReport.asp?organ=HT&rptType=all&continent=4 Accessed July 20, 2009
7. Densem C.G., Hutchinson I.V., Cooper A., et al. Polymorphism of the transforming growth factor-beta 1 gene correlates with the development of coronary vasculopathy following cardiac transplantation. J Heart Lung Transplant 19 (2000) 551-556
8. Densem C.G., Mutlak A.S., Pravica V., et al. A novel polymorphism of the gene encoding furin, a TGF-beta1 activator, and the influence on cardiac allograft vasculopathy formation. Transplant Immunol 13 (2004) 185-190
9. Danilewicz M., and Wagrowska-Danilewicz M. Correlative insights into the immunoexpression of transforming growth factor beta-1 in acutely rejected renal allografts. Pathol Res Pract 202 (2006) 9-15
10. DiFilippo S., Zeevi A., McDade K.K., et al. Impact of TGFbeta1 gene polymorphisms on late renal function in pediatric heart transplantation. Hum Immunol 66 (2005) 133-139
11. El-Gamel A., Sim E., Hasleton P., et al. Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation. J Heart Lung Transplant 18 (1999) 828-837
12. George J.F. Immunology in relation to cardiac transplantation. In: Kirklin J.K., Young J.B., and McGiffin D.C. (Eds). Heart transplantation (2001), Churchill Livingstone, New York 14
13. Xiao Y.Q., Freire-de-Lima C.G., Janssen W.J., et al. Oxidants selectively reverse TGF-beta suppression of proinflammatory mediator production. J Immunol 176 (2006) 1209-1217
14. Wynn C., Pan F., Erickson L., et al. High level of TGF-beta in organ transplantation might be due to rejection rather than calcineurin inhibitor medication. Transplant Proc 34 (2002) 1387-1389
15. Saxena V., Lienesch D.W., Zhou M., et al. Dual roles of immunoregulatory cytokine TGF-beta in the pathogenesis of autoimmunity-mediated organ damage. J Immunol 180 (2008) 1903-1912
16. Pascual G., Mendieta C., Garcia-Honduvilla N., et al. TGF-beta1 upregulation in the aging varicose vein. J Vasc Res 44 (2007) 192-201
17. Tambur A.R., Pamboukian S., Costanzo M.R., et al. Genetic polymorphism in platelet-derived growth factor and vascular endothelial growth factor are significantly associated with cardiac allograft vasculopathy. J Heart Lung Transplant 25 (2006) 690-698